Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

A Study of Patient Satisfaction and Uncertainty in a Rapid Access Chest Pain Clinic.

Lembo RJ, Gullick J, Chow CK, Figtree GA, Kozor R.

Heart Lung Circ. 2020 Mar 7. pii: S1443-9506(20)30064-0. doi: 10.1016/j.hlc.2020.01.016. [Epub ahead of print]

PMID:
32192829
2.

Myocardial Edema, Myocyte Injury, and Disease Severity in Fabry Disease.

Augusto JB, Nordin S, Vijapurapu R, Baig S, Bulluck H, Castelletti S, Alfarih M, Knott K, Captur G, Kotecha T, Ramaswami U, Tchan M, Geberhiwot T, Fontana M, Steeds RP, Hughes D, Kozor R, Moon JC.

Circ Cardiovasc Imaging. 2020 Mar;13(3):e010171. doi: 10.1161/CIRCIMAGING.119.010171. Epub 2020 Mar 2.

PMID:
32114828
3.

Cardiovascular Magnetic Resonance Imaging of Inherited Heart Conditions.

Dennis M, Ugander M, Kozor R, Puranik R.

Heart Lung Circ. 2020 Apr;29(4):584-593. doi: 10.1016/j.hlc.2019.12.008. Epub 2019 Dec 24. Review.

PMID:
32033894
4.

Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy.

Nordin S, Kozor R, Vijapurapu R, Augusto JB, Knott KD, Captur G, Treibel TA, Ramaswami U, Tchan M, Geberhiwot T, Steeds RP, Hughes DA, Moon JC.

Circ Cardiovasc Imaging. 2019 Dec;12(12):e009430. doi: 10.1161/CIRCIMAGING.119.009430. Epub 2019 Dec 12.

5.

The electrical determinants of increased wall thickness and mass in left ventricular hypertrophy.

Maanja M, Schlegel TT, Kozor R, Lundin M, Wieslander B, Wong TC, Schelbert EB, Ugander M.

J Electrocardiol. 2020 Jan - Feb;58:80-86. doi: 10.1016/j.jelectrocard.2019.09.024. Epub 2019 Nov 13.

PMID:
31785580
6.

Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy.

Vijapurapu R, Geberhiwot T, Jovanovic A, Baig S, Nordin S, Kozor R, Leyva F, Kotecha D, Wheeldon N, Deegan P, Rusk RA, Moon JC, Hughes DA, Woolfson P, Steeds RP.

Heart. 2019 Dec;105(23):1825-1831. doi: 10.1136/heartjnl-2019-315229. Epub 2019 Aug 24.

7.

Quantitative Myocardial Perfusion in Fabry Disease.

Knott KD, Augusto JB, Nordin S, Kozor R, Camaioni C, Xue H, Hughes RK, Manisty C, Brown LAE, Kellman P, Ramaswami U, Hughes D, Plein S, Moon JC.

Circ Cardiovasc Imaging. 2019 Jul;12(7):e008872. doi: 10.1161/CIRCIMAGING.119.008872. Epub 2019 Jul 4.

PMID:
31269811
8.

A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice.

Vijapurapu R, Kozor R, Hughes DA, Woolfson P, Jovanovic A, Deegan P, Rusk R, Figtree GA, Tchan M, Whalley D, Kotecha D, Leyva F, Moon J, Geberhiwot T, Steeds RP.

Trials. 2019 May 31;20(1):314. doi: 10.1186/s13063-019-3425-1.

9.

Progressive cardiac involvement in a compound heterozygote Fabry patient: a case report.

McConnell EJ, Every J, Tchan M, Kozor R.

Eur Heart J Case Rep. 2018 Dec 7;2(4):yty122. doi: 10.1093/ehjcr/yty122. eCollection 2018 Dec.

10.

Variation in cardiovascular magnetic resonance myocardial contouring: Insights from an international survey.

Moody WE, Hudsmith LE, Holloway B, Treibel TA, Davies R, Kozor R, Hamilton-Craig C, Edwards NC, Bradlow WM, Moon JC, Steeds RP; British Society of Cardiovascular Magnetic Resonance and the Australia and New Zealand Working Group for Cardiovascular Magnetic Resonance.

J Magn Reson Imaging. 2019 Oct;50(4):1336-1338. doi: 10.1002/jmri.26689. Epub 2019 Feb 17.

11.

Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.

Vijapurapu R, Nordin S, Baig S, Liu B, Rosmini S, Augusto J, Tchan M, Hughes DA, Geberhiwot T, Moon JC, Steeds RP, Kozor R.

Heart. 2019 Mar;105(6):470-476. doi: 10.1136/heartjnl-2018-313699. Epub 2018 Oct 3.

PMID:
30282640
12.

Response by Kozor et al to Letter Regarding Article, "Left Ventricular Hypertrophy Revisited: Cell and Matrix Expansion Have Disease-Specific Relationships".

Kozor R, Moon JC, Treibel TA.

Circulation. 2018 Jun 12;137(24):2672-2673. doi: 10.1161/CIRCULATIONAHA.118.034136. No abstract available.

PMID:
29891630
13.

Diagnosis and treatment of the cardiovascular consequences of Fabry disease.

Baig S, Vijapurapu R, Alharbi F, Nordin S, Kozor R, Moon J, Bembi B, Geberhiwot T, Steeds RP.

QJM. 2019 Jan 1;112(1):3-9. doi: 10.1093/qjmed/hcy120. Review.

PMID:
29878206
14.

Cardiac Phenotype of Prehypertrophic Fabry Disease.

Nordin S, Kozor R, Baig S, Abdel-Gadir A, Medina-Menacho K, Rosmini S, Captur G, Tchan M, Geberhiwot T, Murphy E, Lachmann R, Ramaswami U, Edwards NC, Hughes D, Steeds RP, Moon JC.

Circ Cardiovasc Imaging. 2018 Jun;11(6):e007168. doi: 10.1161/CIRCIMAGING.117.007168.

15.

Proposed Stages of Myocardial Phenotype Development in Fabry Disease.

Nordin S, Kozor R, Medina-Menacho K, Abdel-Gadir A, Baig S, Sado DM, Lobascio I, Murphy E, Lachmann RH, Mehta A, Edwards NC, Ramaswami U, Steeds RP, Hughes D, Moon JC.

JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1673-1683. doi: 10.1016/j.jcmg.2018.03.020. Epub 2018 May 16.

PMID:
29778854
16.

Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis.

Treibel TA, Kozor R, Schofield R, Benedetti G, Fontana M, Bhuva AN, Sheikh A, López B, González A, Manisty C, Lloyd G, Kellman P, Díez J, Moon JC.

J Am Coll Cardiol. 2018 Feb 27;71(8):860-871. doi: 10.1016/j.jacc.2017.12.035.

17.

Left Ventricular Hypertrophy Revisited: Cell and Matrix Expansion Have Disease-Specific Relationships.

Treibel TA, Kozor R, Menacho K, Castelletti S, Bulluck H, Rosmini S, Nordin S, Maestrini V, Fontana M, Moon JC.

Circulation. 2017 Dec 19;136(25):2519-2521. doi: 10.1161/CIRCULATIONAHA.117.029895. No abstract available.

PMID:
29255128
18.

Sex Dimorphism in the Myocardial Response to Aortic Stenosis.

Treibel TA, Kozor R, Fontana M, Torlasco C, Reant P, Badiani S, Espinoza M, Yap J, Diez J, Hughes AD, Lloyd G, Moon JC.

JACC Cardiovasc Imaging. 2018 Jul;11(7):962-973. doi: 10.1016/j.jcmg.2017.08.025. Epub 2017 Nov 15.

19.

Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice.

Baig S, Edward NC, Kotecha D, Liu B, Nordin S, Kozor R, Moon JC, Geberhiwot T, Steeds RP.

Europace. 2018 Sep 1;20(FI2):f153-f161. doi: 10.1093/europace/eux261.

PMID:
29045633
20.

Impact of obesity and epicardial fat on early left atrial dysfunction assessed by cardiac MRI strain analysis.

Evin M, Broadhouse KM, Callaghan FM, McGrath RT, Glastras S, Kozor R, Hocking SL, Lamy J, Redheuil A, Kachenoura N, Fulcher GR, Figtree GA, Grieve SM.

Cardiovasc Diabetol. 2016 Dec 22;15(1):164. doi: 10.1186/s12933-016-0481-7.

21.

Cardiovascular magnetic resonance, mitral regurgitation and outcomes: the importance of accurate assessment in an era of increasing intervention.

Kozor R, Grieve S, Figtree G, Bhindi R.

J Thorac Dis. 2016 Sep;8(9):E1053-E1056. No abstract available.

22.

Cardiac Fabry Disease With Late Gadolinium Enhancement Is a Chronic Inflammatory Cardiomyopathy.

Nordin S, Kozor R, Bulluck H, Castelletti S, Rosmini S, Abdel-Gadir A, Baig S, Mehta A, Hughes D, Moon JC.

J Am Coll Cardiol. 2016 Oct 11;68(15):1707-1708. doi: 10.1016/j.jacc.2016.07.741. No abstract available.

23.

Insight into hypertrophied hearts: a cardiovascular magnetic resonance study of papillary muscle mass and T1 mapping.

Kozor R, Nordin S, Treibel TA, Rosmini S, Castelletti S, Fontana M, Captur G, Baig S, Steeds RP, Hughes D, Manisty C, Grieve SM, Figtree GA, Moon JC.

Eur Heart J Cardiovasc Imaging. 2017 Sep 1;18(9):1034-1040. doi: 10.1093/ehjci/jew187.

PMID:
27590835
24.

Global Myocardial Edema in Antisynthetase Syndrome Detected by Cardiovascular Magnetic Resonance Mapping Techniques.

Sado DM, Kozor R, Corr L, Moon JC.

Circulation. 2016 Jan 19;133(3):e25-6. doi: 10.1161/CIRCULATIONAHA.115.017430. No abstract available.

PMID:
26783280
25.

Cardiac involvement in genotype-positive Fabry disease patients assessed by cardiovascular MR.

Kozor R, Grieve SM, Tchan MC, Callaghan F, Hamilton-Craig C, Denaro C, Moon JC, Figtree GA.

Heart. 2016 Feb 15;102(4):298-302. doi: 10.1136/heartjnl-2015-308494. Epub 2016 Jan 4.

PMID:
26729695
26.

Use of multi-velocity encoding 4D flow MRI to improve quantification of flow patterns in the aorta.

Callaghan FM, Kozor R, Sherrah AG, Vallely M, Celermajer D, Figtree GA, Grieve SM.

J Magn Reson Imaging. 2016 Feb;43(2):352-63. doi: 10.1002/jmri.24991. Epub 2015 Jun 30.

PMID:
26130421
27.

Routine aspiration thrombectomy improves the diagnosis and management of embolic myocardial infarction.

Huang AL, Murphy JC, Shaw E, Kozor R, Yan W, Loxton A, Soo Hoo SY, Figtree GA, Rasmussen HH, Hansen PS, Nelson GI, Bhindi R, Ward MR.

Catheter Cardiovasc Interv. 2016 Mar;87(4):642-7. doi: 10.1002/ccd.26047. Epub 2015 Jun 23.

PMID:
26105814
28.

4D Multi-VENC Cardiac MRI: Characterisation of a Functional Stenosis of the Ascending Aorta.

Kozor R, Callaghan FM, Nelson GI, Figtree GA, Grieve SM.

Heart Lung Circ. 2015 Nov;24(11):1134-5. doi: 10.1016/j.hlc.2015.04.181. Epub 2015 May 27. No abstract available.

PMID:
26092750
29.

A disproportionate contribution of papillary muscles and trabeculations to total left ventricular mass makes choice of cardiovascular magnetic resonance analysis technique critical in Fabry disease.

Kozor R, Callaghan F, Tchan M, Hamilton-Craig C, Figtree GA, Grieve SM.

J Cardiovasc Magn Reson. 2015 Feb 21;17:22. doi: 10.1186/s12968-015-0114-4.

30.

Cardiovascular magnetic resonance of a hiatus hernia causing positional cardiac compression.

Cox A, Kozor R, Maestrini V, Sado D, Moon JC.

Eur Heart J Cardiovasc Imaging. 2015 Jul;16(7):818. doi: 10.1093/ehjci/jev088. Epub 2015 Apr 6. No abstract available.

PMID:
25851326
31.

Regular cocaine use is associated with increased systolic blood pressure, aortic stiffness and left ventricular mass in young otherwise healthy individuals.

Kozor R, Grieve SM, Buchholz S, Kaye S, Darke S, Bhindi R, Figtree GA.

PLoS One. 2014 Apr 9;9(4):e89710. doi: 10.1371/journal.pone.0089710. eCollection 2014.

32.

Pop goes the balloon: a cautionary tale in transaortic intervention.

Kozor R, Murphy JC, Choong C, Hansen P, Bhindi R.

Cardiovasc Interv Ther. 2015 Jan;30(1):82-4. doi: 10.1007/s12928-014-0256-6. Epub 2014 Mar 5.

PMID:
24595875
33.

Fabry disease deposition mimicking a cardiac tumour and precipitating heart block.

Kozor R, Pollock C, Gill A, Bhindi R, Figtree GA.

Eur Heart J Cardiovasc Imaging. 2014 Aug;15(8):869. doi: 10.1093/ehjci/jeu017. Epub 2014 Feb 20. No abstract available.

PMID:
24562183
34.

Procedural and in-patient outcomes in patients aged 80 years or older undergoing contemporary primary percutaneous coronary intervention.

Murphy JC, Kozor RA, Figtree G, Hansen PS, Rasmussen HH, Ward MR, Nelson GI, Bhindi R.

EuroIntervention. 2012 Dec 20;8(8):912-9. doi: 10.4244/EIJV8I8A140.

35.

Percutaneous coronary intervention via the radial artery: comparison of procedural success in emergency versus non-emergency cases.

Murphy JC, Kozor R, Figtree GA, Ward MR, Bhindi R.

Cardiovasc Revasc Med. 2012 Sep-Oct;13(5):277-80. doi: 10.1016/j.carrev.2012.07.004.

PMID:
22980433
36.

The pain of giving up smoking.

Kozor R, Bhindi R.

Int J Cardiol. 2012 Jan 26;154(2):190-1. doi: 10.1016/j.ijcard.2011.10.083. Epub 2011 Nov 25. No abstract available.

PMID:
22119319
37.

Extensive mid-wall myocardial oedema after aborted sudden death in hypertrophic cardiomyopathy.

Kozor R, Nelson GC, Figtree GA.

Int J Cardiol. 2012 Jan 12;154(1):e14-5. doi: 10.1016/j.ijcard.2011.04.027. Epub 2011 May 24. No abstract available.

PMID:
21605920

Supplemental Content

Support Center